Incorporating anti-VEGF pathway therapy as a continuum of care in metastatic colorectal cancer.


Metastatic cancer was previously treated with distinctive lines of chemotherapy regimens upon disease progression or toxicity, yet the choices of therapy are actually interrelated, with the selection of a first-line regimen in part determining the choices available for subsequent treatment. Lately the therapeutic approach based on separate lines of… (More)
DOI: 10.1007/s11864-015-0333-9


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.